C A Richards - Concepedia

Concepedia

Author

C A Richards

Research Triangle Park Foundation

Also Known As

C A Richards, C Richards, C. A. Richards, C. Richards, Cindy Richards, Johnson, John

21

Publications

2.3K

Citations

18

H-Index

67

Concepts

All Affiliations

Research Triangle Park Foundation Foundation Center University of California, Davis GlaxoSmithKline (United States)

CA

About

C A Richards is an author at Research Triangle Park Foundation specializing in medicine, natural sciences, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	2.1K
2	Natural Sciences	6	6	742
3	Biochemistry	4	4	632
4	Cell Biology	4	4	875
5	Engineering	1	1	29

C A Richards

×

19

Publications

2.3K

Citations

18

H-Index

	Year	Citations
Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Brian E. Huber, Elizabeth A. Austin, C A Richards, Proceedings of the National Academy of Sciences Cytosine DeaminaseImmunologyCancer BiologyGliomaTumor Mass	1994	420
Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Brian E. Huber, C A Richards, Thomas A. Krenitsky Proceedings of the National Academy of Sciences Viral ReplicationSynthetic VirologyImmunologyPathologyVzv Tk-dependent Anabolism	1991	314
3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase M H St Clair, C A Richards, T Spector, Antimicrobial Agents and Chemotherapy ImmunologyMolecular BiologyAntiviral DrugChemical BiologyMedicinal Chemistry	1987	279
In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Brian E. Huber, Elizabeth A. Austin, Steven S. Good, PubMed Widr CellsCytosine DeaminaseChemoprevention StrategyOncogenic AgentMedicine	1993	230
Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. Richard B. Gayle, C R Maliszewski, Steven D. Gimpel, Journal of Clinical Investigation Platelet BiologyThrombosisInflammationEndothelial Cell Cd39Recombinant Soluble Ecto-adpase/cd39	1998	188
Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U) Lynn P. Elwell, Robert Ferone, George A. Freeman, Antimicrobial Agents and Chemotherapy Thymidine AnalogBioorganic ChemistryMicrobial PathogensAntibacterial ActivityEscherichia Coli	1987	158
The nucleotide sequence of the trimethoprim-resistant dihydrofolate reductase gene harbored by Tn7 Mary E. Fling, C A Richards Nucleic Acids Research GeneticsMolecular BiologyMolecular GeneticsGenomicsRedox Biology	1983	109
Seroepidemiology of viral infections among intravenous drug users in northern California. Jerome B. Zeldis, Suchita Jain, I. K. Kuramoto, PubMed Virus EpidemiologyImmunologyHepatitis BNorthern CaliforniaViral Hepatitis	1992	91
Nucleotide sequence of the transposon Tn7 gene encoding an aminoglycoside-modifying enzyme, 3″(9)-<i>O</i>-nucleotidyltransferase Mary E. Flung, Jan Kopf, C A Richards Nucleic Acids Research BacteriologyMolecular BiologyDna SequencesAada Structural GeneDrug Resistance	1985	86
The nucleotide sequence of Saccharomyces cerevisiae chromosome IV C. Jacq, J. Alt-Mörbe, Bruno André, Nature ChromatinChromosome IvChromatin StructureNatural SciencesGenetics	1997	80

Page 1